Join ProSciento at the 61st European Association for the Study of Diabetes Annual Meeting
Stop by booth B5.01 to connect with ProSciento at the European Association for the Study of Diabetes (EASD) Annual Meeting.
Meet our team of experts and discover how ProSciento’s specialized expertise in designing and conducting clinical trials for metabolic diseases can give your therapeutic and device programs a competitive advantage.
As the leading clinical research organization (CRO) focused on diseases across the metabolic continuum, ProSciento is dedicated to advancing research and therapeutic development with unmatched expertise in diabetes, obesity, and steatotic liver diseases.
Our science-driven experts understand the complexities and interconnectedness of diabetes and metabolic diseases, providing customized CRO solutions from study startup to completion. With expertise in glucose-lowering drugs, insulin analogs, and biosimilars, we design patient-focused strategies to improve access, engagement, and trial success. By listening to patients, we optimize research outcomes and accelerate clinical advancements.
Together, we can bring better treatments to patients and advance the future of metabolic disease therapeutics.
